Navigation Links
Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill
Date:2/6/2009

KENSINGTON, Md., Feb. 6 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy organization, has launched a micro-Web site, www.StimulateResearch.com, to help everyday Americans interested in medical research be heard in the stimulus debate that has been dominated by powerful lobbyists and special interests. The Web site allows people to write their lawmakers urging them to make biomedical research a meaningful part of any stimulus bill that emerges in the coming days. The nearly $1 trillion bill sweeping through Congress could crowd out medical research funding at the National Institutes of Health (NIH) for years to come.

"This is the fastest I have seen Washington allocate $1 trillion in my quarter century following politics," said Michael Paranzino, president of Psoriasis Cure Now. "It seems to have caught the patient advocacy community flat-footed. But medical research is every bit as 'shovel ready' and 'stimulative' as Austin's proposed Frisbee golf course or the projects Chicago won't even disclose. Dollars wasted now will not cure cancer, arthritis or psoriasis tomorrow. Our Web site lets Americans concerned about curing disease make sure medical research is not neglected as the final stimulus package is hammered out in the coming week."

The House-passed stimulus bill includes a few billion for NIH (much of it to build new buildings), and the current Senate version includes $10 billion for NIH over two years. But a bipartisan group of Senators is looking to cut more than $100 billion from the current version, and the House-Senate Conference Committee is expected to make significant additional revisions, meaning the fate of medical research is highly uncertain. For the last five years, NIH funding has been stagnant, with thousands of well-designed and 'shovel ready' grant requests by scientists from all 50 states being held up by a lack of funding.

Psoriasis Cure Now takes no position on whether the stimulus bill should pass or fail; rather, it is pointing out that spending $1 trillion in lobbyist-driven spending now could mean that vital NIH research could be starved for years to come. Its www.StimulateResearch.com site is designed to give everyday Americans a chance to be part of this debate as well.

"Silence may be golden when it's time for my kids to go to bed, but silence by patient advocates is definitely not golden during this stimulus debate," Paranzino added. "The asphalt lobbyists, the honey bee lobbyists, the state politician lobbyists --- all are out in force, seeking parts of the one trillion dollars in play. It's essential that people who want cures for AIDS, MS, autism, heart disease and diabetes be heard as well. StimulateResearch.com lets us be heard."

http://www.psoriasis-cure-now.org


'/>"/>
SOURCE Psoriasis Cure Now
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
2. Gene Insights May Improve Psoriasis Care
3. Scientists unmask genetic markers associated with psoriasis
4. An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe
5. Obesity-Related Hormone Tied to Psoriasis
6. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
7. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
8. Indigo Ointment Benefits Psoriasis Patients
9. National Psoriasis Foundation Seeks 10,000 Americans to Support Psoriasis Research for World Psoriasis Day
10. National Psoriasis Foundation Releases 2008 Study Results
11. After Fits and Starts, New Hope for Psoriasis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Apple Rehab ... services, staged a mock evacuation of the facility as part of a disaster drill ... Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: